{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T09:58:22Z","timestamp":1777111102718,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,1,12]],"date-time":"2006-01-12T00:00:00Z","timestamp":1137024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,1,12]],"date-time":"2006-01-12T00:00:00Z","timestamp":1137024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2006,2,1]]},"DOI":"10.1038\/sj.jp.7211440","type":"journal-article","created":{"date-parts":[[2006,1,12]],"date-time":"2006-01-12T05:51:47Z","timestamp":1137045107000},"page":"120-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A pilot trial testing the feasibility of administering D-penicillamine to extremely low birth weight neonates"],"prefix":"10.1038","volume":"26","author":[{"given":"R D","family":"Christensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S C","family":"Alder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S C","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J T","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D K","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V L","family":"Baer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,1,12]]},"reference":[{"key":"BF7211440_CR1","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1542\/peds.114.2.490","volume":"114","author":"DL Phelps","year":"2004","unstructured":"Phelps DL, ETROP Cooperative Group. The early treatment for retinopathy of prematurity study: better outcomes, changing strategy. Pediatrics 2004; 114: 490\u2013491.","journal-title":"Pediatrics"},{"key":"BF7211440_CR2","doi-asserted-by":"publisher","first-page":"F240","DOI":"10.1136\/adc.2004.057570","volume":"90","author":"L Haines","year":"2005","unstructured":"Haines L, Fielder AR, Baker H, Wilkinson AR . UK population based study of severe retinopathy of prematurity: screening, treatment, and outcome. Arch Dis Child Fetal Neonatal Ed 2005; 90: F240\u2013F244.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"BF7211440_CR3","unstructured":"http:\/\/www.nei.nih.gov\/health\/rop\/index.asp."},{"key":"BF7211440_CR4","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1001\/archopht.1996.01100140452016","volume":"114","author":"LP Aiello","year":"1996","unstructured":"Aiello LP . Vascular endothelial growth factor and the eye \u2013 past, present, and future. Arch Ophthalmol 1996; 114: 1252\u20131254.","journal-title":"Arch Ophthalmol"},{"key":"BF7211440_CR5","first-page":"1647","volume":"38","author":"LP Aiello","year":"1997","unstructured":"Aiello LP . Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies. Investig Ophthalmol Vis Sci 1997; 38: 1647\u20131652.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"BF7211440_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/10715760410001684621","volume":"38","author":"C Polytarchou","year":"2004","unstructured":"Polytarchou C, Papadimitriou E . Antioxidants inhibit angiogenesis in vivo through down-regulation of nitric oxide synthase expression and activity. Free Radic Res 2004; 38: 501\u2013508.","journal-title":"Free Radic Res"},{"key":"BF7211440_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/10623320214733","volume":"9","author":"JS Stone","year":"2002","unstructured":"Stone JS, Collins T . The role of hydrogen peroxide in endothelial proliferative responses. Endothelium 2002; 9: 231\u2013238.","journal-title":"Endothelium"},{"key":"BF7211440_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1023\/B:MCBI.0000044378.09409.b5","volume":"264","author":"M Ushio-Fukai","year":"2004","unstructured":"Ushio-Fukai M, Alexander RW . Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxide. Mol Cell Biochem 2004; 264: 85\u201397.","journal-title":"Mol Cell Biochem"},{"key":"BF7211440_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1399-3011.1993.tb00139.x","volume":"42","author":"JT Hunt","year":"1993","unstructured":"Hunt JT, Lee VG, Liu EC, Moreland S, McMullen D, Webb ML et al. Control of peptide disulfide regioisomer formation by mixed cysteine-penicillamine bridges. Int J Peptide Protein Res 1993; 42: 249\u2013258.","journal-title":"Int J Peptide Protein Res"},{"key":"BF7211440_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1172\/JCI113853","volume":"83","author":"T Matsubara","year":"1989","unstructured":"Matsubara T, Saura R, Hirohata K . Inhibition of human endothelial cell proliferation in vitro and neovasularization in vivo by D-penicillamine. J Clin Invest 1989; 83: 158\u2013167.","journal-title":"J Clin Invest"},{"key":"BF7211440_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1227\/00006123-199508000-00014","volume":"37","author":"D Yoshida","year":"1995","unstructured":"Yoshida D, Ikeda Y, Nakazawa S . Copper chelation inhibits tumor angiogenesis in the experimental 9L gliosarcoma model. Neurosurgery 1995; 37: 287\u2013292.","journal-title":"Neurosurgery"},{"key":"BF7211440_CR12","doi-asserted-by":"publisher","first-page":"7177","DOI":"10.1021\/bi00021a032","volume":"34","author":"D Pietraforte","year":"1995","unstructured":"Pietraforte D, Mallozzi C, Scorza G, Minetti M . Role of thiols in the targeting of S-nitroso thiols to red blood cells. Biochemistry 1995; 34: 7177\u20137185.","journal-title":"Biochemistry"},{"key":"BF7211440_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1006\/exer.1994.1133","volume":"59","author":"NA McBrien","year":"1994","unstructured":"McBrien NA, Norton TT . Prevention of collagen crosslinking increases form-deprivation myopia in tree shrew. Exp Eye Res 1994; 59: 475\u2013486.","journal-title":"Exp Eye Res"},{"key":"BF7211440_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1006\/bbrc.1996.0730","volume":"222","author":"G Siemeister","year":"1996","unstructured":"Siemeister G, Schnurr B, Mohrs K, Schachtele C, Marme D, Martiny-aron G . Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli. Biochem Biophys Res Commun 1996; 222: 249\u2013255.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF7211440_CR15","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF00442643","volume":"123","author":"L Lakatos","year":"1976","unstructured":"Lakatos L, Kover B, Oroszlan GY, Vekerdy ZS . Penicillamine therapy in ABO hemolytic disease of the newborn infant. Eur J Pediatr 1976; 123: 133\u2013137.","journal-title":"Eur J Pediatr"},{"key":"BF7211440_CR16","first-page":"47","volume":"27","author":"L Lakatos","year":"1986","unstructured":"Lakatos L, Hatvani I, Oroszlan G, Balla G, Karmazsin L, Alaka O et al. Controlled trial of D-penicillamine to prevent retinopathy of prematurity. Acta Paediatr Hungar 1986; 27: 47\u201356.","journal-title":"Acta Paediatr Hungar"},{"key":"BF7211440_CR17","first-page":"CD001073","volume":"1","author":"DL Phelps","year":"2001","unstructured":"Phelps DL, Lakatos L, Watts JL . Penicillamine for preventing retinopathy of prematurity in preterm infants. Cochrane Database Syst Rev 2001; 1: CD001073.","journal-title":"Cochrane Database Syst Rev"},{"key":"BF7211440_CR18","doi-asserted-by":"crossref","unstructured":"An International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity Revisited. Arch Ophthalmol 2005; 123: 991\u2013995.","DOI":"10.1001\/archopht.123.7.991"},{"key":"BF7211440_CR19","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S0161-6420(01)00540-1","volume":"108","author":"WV Good","year":"2001","unstructured":"Good WV, Hardy RJ . The multicenter study of early treatment for retinopathy of prematurity (ETROP). Ophthalmology 2001; 108: 1013\u20131014.","journal-title":"Ophthalmology"},{"key":"BF7211440_CR20","doi-asserted-by":"publisher","first-page":"e518","DOI":"10.1542\/peds.2004-1180","volume":"115","author":"C Gilbert","year":"2005","unstructured":"Gilbert C, Fielder A, Gordillo L, Guinn G, Semiglia R, Visintin P et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: Implication for screening programs. Pediatrics 2005; 115: e518\u2013e525.","journal-title":"Pediatrics"},{"key":"BF7211440_CR21","volume-title":"The Cochrane Library","author":"DL Phelps","year":"1997","unstructured":"Phelps DL, Watts JL . Early light reduction to prevent retinopathy of prematurity in very low birth weight infants. In: The Cochrane Library, Issue 1, 1997. Oxford: Update Software."},{"key":"BF7211440_CR22","doi-asserted-by":"crossref","unstructured":"STOP-ROP Multicenter Trial. Supplemental therapeutic oxygen for prethrehold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics 2000; 105: 295\u2013310.","DOI":"10.1542\/peds.105.2.295"},{"issue":"Suppl 2","key":"BF7211440_CR23","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/sj.jp.7211321","volume":"25","author":"OD Saugstad","year":"2005","unstructured":"Saugstad OD . Oxygen for newborns: How much is too much? J Perinatol 2005; 25 (Suppl 2): S45\u2013S49.","journal-title":"J Perinatol"},{"key":"BF7211440_CR24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/01.moh.0000130309.44976.ad","volume":"11","author":"JA Alva","year":"2004","unstructured":"Alva JA, Inuela-Arispe ML . Notch signaling in vascular morphogenesis. Curr Op Hematol 2004; 11: 278\u2013293.","journal-title":"Curr Op Hematol"},{"key":"BF7211440_CR25","first-page":"93","volume":"17","author":"L Lakatos","year":"1976","unstructured":"Lakatos L, Kover B, Vekerdy ZS, Dvoracsdk E . D-penicillamine therapy in neonatal jaundice: comparison with phototherapy. Acta Paediatr Acad Sci Hungar 1976; 17: 93\u2013102.","journal-title":"Acta Paediatr Acad Sci Hungar"},{"key":"BF7211440_CR26","first-page":"9","volume":"19","author":"G Koranyi","year":"1978","unstructured":"Koranyi G, Kovacs J, Voros I . Penicillamine treatment of hyperbilirubinemia in preterm infants. Acta Paediatr Acad Sci Hungar 1978; 19: 9\u201316.","journal-title":"Acta Paediatr Acad Sci Hungar"},{"key":"BF7211440_CR27","first-page":"580","volume":"15","author":"AA Drosos","year":"1997","unstructured":"Drosos AA, Geogriou P, Politi EN, Voulgari PV . D-penicillamine in early rheumatoid arthritis. Clin Exper Rheumatol 1997; 15: 580.","journal-title":"Clin Exper Rheumatol"},{"key":"BF7211440_CR28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/ajmg.a.10871","volume":"128","author":"R Pinter","year":"2004","unstructured":"Pinter R, Hogge WA, McPherson E . Infant with severe penicillamine embryopathy born to a woman with Wilson disease. Am J Med Genet A 2004; 128: 294\u2013298.","journal-title":"Am J Med Genet A"},{"key":"BF7211440_CR29","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/0002-9378(93)90163-D","volume":"169","author":"M Oga","year":"1993","unstructured":"Oga M, Matsui N, Anai T, Yoshimatsu J, Inoue I, Miyakawa I . Copper disposition of the fetus and placenta in a patient with untreated Wilson's disease. Am J Obstet Gynecol 1993; 169: 196\u2013198.","journal-title":"Am J Obstet Gynecol"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7211440.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7211440","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7211440.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T12:19:34Z","timestamp":1647605974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7211440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,12]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2,1]]}},"alternative-id":["BF7211440"],"URL":"https:\/\/doi.org\/10.1038\/sj.jp.7211440","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,12]]},"assertion":[{"value":"15 August 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2006","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}